Michael T. Montgomery

Michael T. Montgomery

Auto-generated profile, based on publicly available information

Michael T. Montgomery

Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Open access
MPMichael C. Peters
Michael C. Peters
SSSatria Sajuthi
Satria Sajuthi
PDPeter Deford
Peter Deford
SCStephanie Christenson
Stephanie Christenson
CRCydney L. Rios
Cydney L. Rios
BIBlood Institute Severe Asthma Research Program-3 Investigators
Blood Institute Severe Asthma Research Program-3 Investigators
Rationale: Coronavirus disease (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). ACE2 (angiotensin-converting enzyme 2), and TMPRSS2 (transmembrane protease serine 2) mediate viral infection of host cells. We reasoned that differences in ACE2 or TMPRSS2 gene expression in sputum cells among patients with asthma may identify subgroups at risk for COVID-19 morbidity. Objectives: To determine the relationship between demographic features and sputum ACE2 and TMPRSS2 gene expression in asthma. Methods: We analyzed gene expression for ACE2 and TMPRSS2, and for ICAM-1 (intercellular adhesion molecule 1) (rhinovirus receptor as a comparator) in sputum cells from 330 participants in SARP-3 (Severe Asthma Research Program-3) and 32 healthy control subjects. Measurements and Main Results: Gene expression of ACE2 was lower than TMPRSS2, and expression levels of both genes were similar in asthma and health. Among patients with asthma, male sex, African American race, and history of diabetes mellitus were associated with higher expression of ACE2 and TMPRSS2. Use of inhaled corticosteroids (ICS) was associated with lower expression of ACE2 and TMPRSS2, but treatment with triamcinolone acetonide did not decrease expression of either gene. These findings differed from those for ICAM-1, where less consistent differences in gene expression were observed related to sex, race, and use of ICS. Conclusions: Higher expression of ACE2 and TMPRSS2 in males, African Americans, and patients with diabetes mellitus provides rationale for monitoring these asthma subgroups for poor COVID-19 outcomes. The lower expression of ACE2 and TMPRSS2 with ICS use warrants prospective study of ICS use as a predictor of decreased susceptibility to SARS-CoV-2 infection and decreased COVID-19 morbidity.

19 May 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
KGKatherine C Goldfarbmuren
Katherine C Goldfarbmuren
NJNathan D. Jackson
Nathan D. Jackson
SSSatria P. Sajuthi
Satria P. Sajuthi
NDNathan Dyjack
Nathan Dyjack
KLKatie S. Li
Katie S. Li
MSMax A. Seibold
Max A. Seibold
Cigarette smoke first interacts with the lung through the cellularly diverse airway epithelium and goes on to drive development of most chronic lung diseases. Here, through single cell RNA-sequencing analysis of the tracheal epithelium from smokers and non-smokers, we generate a comprehensive atlas of epithelial cell types and states, connect these into lineages, and define cell-specific responses to smoking. Our analysis infers multi-state lineages that develop into surface mucus secretory and ciliated cells and then contrasts these to the unique specification of submucosal gland (SMG) cells. Accompanying knockout studies reveal that tuft-like cells are the likely progenitor of both pulmonary neuroendocrine cells and CFTR-rich ionocytes. Our smoking analysis finds that all cell types, including protected stem and SMG populations, are affected by smoking through both pan-epithelial smoking response networks and hundreds of cell-specific response genes, redefining the penetrance and cellular specificity of smoking effects on the human airway epithelium.

20 February 2019 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
DLDonald Y.M. Leung
Donald Y.M. Leung
ACAgustin Calatroni
Agustin Calatroni
LZLivia S. Zaramela
Livia S. Zaramela
PLPetra K. LeBeau
Petra K. LeBeau
NDNathan Dyjack
Nathan Dyjack
EGElena Goleva
Elena Goleva
Skin barrier dysfunction has been reported in both atopic dermatitis (AD) and food allergy (FA). However, only one-third of patients with AD have FA. The purpose of this study was to use a minimally invasive skin tape strip sampling method and a multiomics approach to determine whether children with AD and FA (AD FA+) have stratum corneum (SC) abnormalities that distinguish them from AD without FA (AD FA−) and nonatopic (NA) controls. Transepidermal water loss was found to be increased in AD FA+. Filaggrin and the proportion of ω-hydroxy fatty acid sphingosine ceramide content in nonlesional skin of children with AD FA+ were substantially lower than in AD FA− and NA skin. These abnormalities correlated with morphologic changes in epidermal lamellar bilayer architecture responsible for barrier homeostasis. Shotgun metagenomic studies revealed that the nonlesional skin of AD FA+ had increased abundance of Staphylococcus aureus compared to NA. Increased expression of keratins 5, 14, and 16 indicative of hyperproliferative keratinocytes was observed in the SC of AD FA+. The skin transcriptome of AD FA+ had increased gene expression for dendritic cells and type 2 immune pathways. A network analysis revealed keratins 5, 14, and 16 were positively correlated with AD FA+, whereas filaggrin breakdown products were negatively correlated with AD FA+. These data suggest that the most superficial compartment of nonlesional skin in AD FA+ has unique properties associated with an immature skin barrier and type 2 immune activation.

12 October 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
SSSatria P. Sajuthi
Satria P. Sajuthi
PDPeter DeFord
Peter DeFord
YLYingchun Li
Yingchun Li
NJNathan D. Jackson
Nathan D. Jackson
MMMichael T. Montgomery
Michael T. Montgomery
MSMax A. Seibold
Max A. Seibold
Coronavirus disease 2019 (COVID-19) is caused by SARS-CoV-2, an emerging virus that utilizes host proteins ACE2 and TMPRSS2 as entry factors. Understanding the factors affecting the pattern and levels of expression of these genes is important for deeper understanding of SARS-CoV-2 tropism and pathogenesis. Here we explore the role of genetics and co-expression networks in regulating these genes in the airway, through the analysis of nasal airway transcriptome data from 695 children. We identify expression quantitative trait loci for bothACE2andTMPRSS2, that vary in frequency across world populations. We findTMPRSS2is part of a mucus secretory network, highly upregulated by type 2 (T2) inflammation through the action of interleukin-13, and that the interferon response to respiratory viruses highly upregulatesACE2expression. IL-13 and virus infection mediated effects onACE2expression were also observed at the protein level in the airway epithelium. Finally, we define airway responses to common coronavirus infections in children, finding that these infections generate host responses similar to other viral species, including upregulation ofIL6andACE2. Our results reveal possible mechanisms influencing SARS-CoV-2 infectivity and COVID-19 clinical outcomes.

8 July 2022 in JCI Insight
Verified
Journal Article
Open access
PDF file
MKMaya E. Kotas
Maya E. Kotas
CMCamille M. Moore
Camille M. Moore
JGJose G. Gurrola
Jose G. Gurrola
SPSteven D. Pletcher
Steven D. Pletcher
AGAndrew N. Goldberg
Andrew N. Goldberg
EGErin D. Gordon
Erin D. Gordon
Chronic type 2 (T2) inflammatory diseases of the respiratory tract are characterized by mucus overproduction and disordered mucociliary function, which are largely attributed to the effects of IL-13 on common epithelial cell types (mucus secretory and ciliated cells). The role of rare cells in airway T2 inflammation is less clear, though tuft cells have been shown to be critical in the initiation of T2 immunity in the intestine. Using bulk and single-cell RNA sequencing of airway epithelium and mouse modeling, we found that IL-13 expanded and programmed airway tuft cells toward eicosanoid metabolism and that tuft cell deficiency led to a reduction in airway prostaglandin E 2 (PGE 2 ) concentration. Allergic airway epithelia bore a signature of PGE 2 activation, and PGE 2 activation led to cystic fibrosis transmembrane receptor–dependent ion and fluid secretion and accelerated mucociliary transport. These data reveal a role for tuft cells in regulating epithelial mucociliary function in the allergic airway.

1 August 2020 in American Journal of Respiratory Cell and Molecular Biology
Verified
Journal Article
Closed access
MMMichael T. Montgomery
Michael T. Montgomery
SSSatria P. Sajuthi
Satria P. Sajuthi
SCSeung-Hyun Cho
Seung-Hyun Cho
JEJamie L. Everman
Jamie L. Everman
CRCydney L. Rios
Cydney L. Rios
MSMax A. Seibold
Max A. Seibold
Air pollution particulate matter 100 genes), which included transcriptional drivers of mucus metaplasia (SPDEF and FOXA3). Exposure to a higher OE dose modified the expression of 1,240 genes and further exacerbated expression responses observed at the moderate dose, including the mucus secretory program. Moreover, the higher OE dose significantly increased the MUC5AC/MUC5B gel-forming mucin expression ratio and strongly downregulated ciliated cell expression programs, including key ciliating cell transcription factors (e.g., FOXJ1 and MCIDAS). Chronic OE stimulation induced mucus metaplasia–like remodeling characterized by increases in MUC5AC+ secretory cells and MUC5AC mucus secretions. This epithelial remodeling may underlie poor respiratory outcomes associated with high PM2.5 exposure.